Phages and antimicrobial proteins in the fight against antimicrobial resistance
INCATE catalyzes critical growth stage at Invitris
11-May-2023 -
INCATE has selected Invitris as the first venture to receive €250,000 in “Stage II Funding” that will allow Invitris to complete spin-out from Chair of Physics of Synthetic Biological Systems at the Technical University of Munich (TUM) and further its mission to scale the production of phages, ...
antimicrobial peptides
antimicrobial resistance
funding
+3